Eastman Chemical jumps as Q2 2026 EPS outlook tops estimates
Eastman Chemical shares rose after the company guided Q2 2026 adjusted EPS to $1.70–$1.90, above the ~$1.67 consensus estimate. The move follows Eastman’s Q1 2026 results released April 30, 2026, as investors focus on a stronger near-term profit outlook.
1. What’s moving the stock
Eastman Chemical (EMN) is trading higher today after issuing second-quarter 2026 adjusted EPS guidance of $1.70 to $1.90, which is above the prevailing consensus estimate around $1.67. The guidance update sparked buying interest as the market reprices near-term earnings momentum. (marketbeat.com)
2. The setup: Q1 results and the pivot to Q2
The guidance arrives right after Eastman’s first-quarter 2026 financial results released on April 30, 2026, which reported adjusted EPS of $1.09 (with year-ago adjusted EPS of $1.91 shown in the company’s earnings tables). With Q2 now guided materially higher than Q1, investors appear to be leaning into a sequential improvement narrative rather than the softer Q1 print. (sec.gov)
3. Why it matters from here
For a cyclical chemicals name, a beat-and-raise on the next quarter often matters more than backward-looking results because it can signal better spreads, improved mix, or faster-than-expected benefit from internal actions. The key near-term question is whether Eastman can sustain the implied step-up beyond Q2 and convert it into steadier earnings visibility for the rest of 2026. (sec.gov)